3213|1736|Public
5|$|Other cell-death {{mechanisms}} include proteasomal and lysosomal system dysfunction {{and reduced}} mitochondrial activity. Iron accumulation in the substantia nigra is typically observed {{in conjunction with}} the protein inclusions. It may be related to oxidative stress, protein aggregation and <b>neuronal</b> <b>death,</b> but the mechanisms are not fully understood.|$|E
5|$|A {{number of}} changes can occur to {{mitochondria}} during the aging process. Tissues from elderly patients show {{a decrease in}} enzymatic activity of the proteins of the respiratory chain. However, mutated mtDNA can only be found in about 0.2% of very old cells. Large deletions in the mitochondrial genome have been hypothesized to lead {{to high levels of}} oxidative stress and <b>neuronal</b> <b>death</b> in Parkinson's disease.|$|E
5|$|Tirilazad is an {{antioxidant}} steroid derivative that inhibits the {{lipid peroxidation}} that {{is believed to}} {{play a key role}} in <b>neuronal</b> <b>death</b> in stroke and head injury. It demonstrated activity in animal models of stroke, but human trials demonstrated no effect on mortality or other outcomes in subarachnoid haemorrhage and worsened results in ischemic stroke.|$|E
40|$|AbstractNeurons may die as {{a normal}} {{physiological}} process during development or as a pathological process in diseases. The best-understood mechanism of <b>neuronal</b> cell <b>death</b> is apoptosis, which is regulated by an evolutionarily conserved cellular pathway that consists of the caspase family, the Bcl- 2 family, and the adaptor protein Apaf- 1. Apoptosis, however, {{may not be the}} only cellular mechanism that regulates <b>neuronal</b> cell <b>death.</b> <b>Neuronal</b> cell <b>death</b> may exhibit morphological features of autophagy or necrosis, which differ from that of the canonical apoptosis. This review evaluates the evidence supporting the existence of alternative mechanisms of <b>neuronal</b> cell <b>death</b> and proposes the possible existence of an evolutionarily conserved pathway of necrosis...|$|R
40|$|AbstractTo {{study the}} {{molecular}} mechanism of <b>neuronal</b> cell <b>death,</b> we {{carried out the}} screening of genes which were induced during the <b>neuronal</b> cell <b>death</b> of <b>neuronal</b> PC 12. We cloned the cDNA of rat GADD 45 γ, the third member of the GADD 45 family. Induction of GADD 45 γ mRNA was observed in the <b>neuronal</b> cell <b>death</b> caused by depletion of neurotrophic factor and Ca 2 + ionophore treatment. Overexpression of GADD 45 γ in superior cervical ganglion neurons caused cell death. These results suggest that GADD 45 γ {{plays an important role}} in <b>neuronal</b> cell <b>death...</b>|$|R
40|$|Neurotoxic {{effects of}} {{excitatory}} amino acids have {{been implicated in}} various neurological disorders, and have been utilized for excitotoxic models of delayed <b>neuronal</b> cell <b>death.</b> The excitotoxic glutamate-induced, delayed <b>neuronal</b> cell <b>death</b> also results in inhibition of calciumlcalmodulin-dependent kinase II (CaM kinase II). In this report, we characterized the glutamate-induced inhibition of CaM kinase II in relation to loss of intracellular calcium regulation and delayed <b>neuronal</b> cell <b>death.</b> Glutamate (500 PM for 10 min), but not KCI (50 mM), exposure resulted in a significant inhibition of CaM kinase II activity. The inhibition of CaM kinase II activity was observed immediately following excitotoxic glutamate exposure and present at every time point measured. Glutamate-induced inhibition of kinase activity and delayed <b>neuronal</b> cell <b>death</b> was dependent upon both the activation of the NMDA glutamate receptor subtype {{and the presence of}} extracellular calcium. The relationship between inhibition of CaM kinase II activity and loss of intracellular calcium regulation was also examined. Experimental conditions which resulted in significant <b>neuronal</b> cell <b>death</b> and inhibition of CaM kinase II activity also resulted in a long-term loss of intracellular calcium regulation. Thus, inhibition of CaM kinase II activity occurred under experimental conditions which resulted in loss of neuronal viability and loss of neuronal calcium regulation. Since the glutamate-induced inhibition of CaM kinase II activity preceded <b>neuronal</b> cell <b>death,</b> the data support the hypothesis that inhibition of CaM kinase II activity may {{play a significant role in}} excitotoxicity-dependent, delayed <b>neuronal</b> cell <b>death.</b> [Key words: excitotoxicity, cell culture, calcium, phosphorylation, glutamate cations, pharmacology] Neurotoxic effects of excitatory amino acids have been implicated in various neurological disorders and have been utilized for excitotoxic models of delayed <b>neuronal</b> cell <b>death</b> (Rothman...|$|R
5|$|Manganese is an {{important}} element for human health, essential for development, metabolism, and the antioxidant system. Nevertheless, excessive exposure or intake {{may lead to a}} condition known as manganism, a neurodegenerative disorder that causes dopaminergic <b>neuronal</b> <b>death</b> and symptoms similar to Parkinson's disease. The classes of enzymes that have manganese cofactors is large and includes oxidoreductases, transferases, hydrolases, lyases, isomerases, ligases, lectins, and integrins. The reverse transcriptases of many retroviruses (though not lentiviruses such as HIV) contain manganese. The best-known manganese-containing polypeptides may be arginase, the diphtheria toxin, and Mn-containing superoxide dismutase (Mn-SOD).|$|E
25|$|Nitrous oxide at 75-vol% reduce ischemia-induced <b>neuronal</b> <b>death</b> {{induced by}} {{occlusion}} {{of the middle}} cerebral artery in rodents, and decrease NMDA-induced Ca2+ influx in neuronal cell cultures, a critical event involved in excitotoxicity.|$|E
25|$|Brain {{ischemia}} {{is characterized}} by insufficient {{blood flow to the}} brain. Studies with ischaemic gerbils indicate that, after a delay, levels of quinolinic acid significantly increase, which correlates with increased neuronal damage. In addition, researchers have found that, after transient global ischaemia, there are microglia containing quinolinic acid within the brain. Following cerebral ischaemia, delayed <b>neuronal</b> <b>death</b> may occur in part because of central microglia and macrophages, which possess and secrete quinolinic acid. This delayed neurodegeneration could be associated with chronic brain damage that follows a stroke.|$|E
50|$|Fustin shows {{protective}} effects on 6-hydroxydopamine-induced <b>neuronal</b> cell <b>death.</b>|$|R
40|$|AbstractMitochondrial {{dysfunction}} is {{a hallmark}} of beta-amyloid (Aβ) -induced neuronal toxicity in Alzheimer’s disease (AD). Epidemiological {{studies have indicated that}} alcohol consumption plays a {{role in the development of}} AD. Here we show that alcohol exposure has a synergistic effect on Aβ-induced <b>neuronal</b> cell <b>death.</b> Aβ-treated cultured neurons displayed spontaneous generation of reactive oxygen species (ROS), disruption of their mitochondrial membrane potential, induction of caspase- 3 and p 53 activities, and loss of cell viability. Alcohol exposure facilitated Aβ-induced <b>neuronal</b> cell <b>death.</b> Our study shows that alcohol consumption enhances Aβ-induced <b>neuronal</b> cell <b>death</b> by increasing ROS and mitochondrial dysfunction...|$|R
40|$|Neuronal {{cell cycle}} {{activation}} has {{been implicated in}} neurodegenerative diseases such as Alzheimer’s disease, while the initiating mechanism of cell cycle activation remains to be determined. Interestingly, our previous {{studies have shown that}} cell cycle activation by c-Myc (Myc) leads to <b>neuronal</b> cell <b>death</b> which suggests Myc might be a key regulator of cell cycle reentry mediated <b>neuronal</b> cell <b>death.</b> However, the pattern of Myc expression in the process of <b>neuronal</b> cell <b>death</b> has not been addressed. To this end, we examined Myc induction by the neurotoxic agents camptothecin and amyloid-β peptide in a differentiated SH-SY 5 Y neuronal cell culture model. Myc expression was found to be significantly increased following either treatment and importantly, the induction of Myc preceded <b>neuronal</b> cell <b>death</b> suggesting it is an early event of <b>neuronal</b> cell <b>death.</b> Since ectopic expression of Myc in neurons causes the cell cycle activation and neurodegeneration in vivo, the current data suggest that induction of Myc by neurotoxic agents or other disease factors might be a key mediator in cell cycle activation and consequent cell death that is a feature of neurodegenerative diseases...|$|R
25|$|Quinolinic acid {{has also}} been found in HAND {{patients}}’ brains. In fact, the amount of quinolinic acid found in the brain of HAND patients can be up to 300 times greater than that found in the CSF. Neurons exposed to quinolinic acid {{for long periods of}} time can develop cytoskeletal abnormalities, vacuolization, and cell death. HAND patients’ brains contain many of these defects. Furthermore, studies in rats have demonstrated that quinolinic acid can lead to <b>neuronal</b> <b>death</b> in brains structures that are affected by HAND, including the striatum, hippocampus, the substantia nigra, and non-limbic cortex.|$|E
25|$|Excitotoxicity is the {{pathological}} {{process by which}} nerve cells are damaged or killed by excessive stimulation by neurotransmitters such as glutamate and similar substances. This occurs when receptors for the excitatory neurotransmitter glutamate (glutamate receptors) such as the NMDA receptor and AMPA receptor are overactivated by glutamatergic storm. Excitotoxins like NMDA and kainic acid which bind to these receptors, as well as pathologically high levels of glutamate, can cause excitotoxicity by allowing high levels of calcium ions (Ca2+) to enter the cell. influx elicited by glutamate: role in <b>neuronal</b> <b>death</b> | url = | journal = Molecular Pharmacoloy | volume = 36 | issue = 1| pages = 106–112 | pmid = 2568579 }} Ca2+ influx into cells activates a number of enzymes, including phospholipases, endonucleases, and proteases such as calpain. These enzymes go on to damage cell structures such as components of the cytoskeleton, membrane, and DNA.|$|E
2500|$|This {{results in}} a major {{decrease}} in axonal sodium channels, which are necessary for action potential propagation. [...] If the stimulation continues, eventually the neuron will stop transmitting action potentials and will die. <b>Neuronal</b> <b>death</b> due to overstimulation is called excitotoxicity.|$|E
40|$|Recent data {{advocate}} for the implication of lysosomes {{in the development of}} programmed cell death. Lysosomal dysfunction decreased the efficiency of autophagosome/lysosome fusion that leads to vacuolation of cells. Autophagic vacuoles containing damaged organelles and altered proteins are hallmarks in most neurodegenerative disorders. These aggregates consequently disrupt cellular homeostasis causing <b>neuronal</b> cell <b>death</b> due apoptosis or necrosis. Moreover calpain mediated or mutation inducted lysosomal rupture result in release of lysosomal cathepsins into the cytoplasm and inducing <b>neuronal</b> cell <b>death.</b> In this review we emphasize the pathophysiological mechanism connecting disrupting autophagy – lysosomal pathway and lysosomal dysfunction in <b>neuronal</b> cell <b>death</b> called lysosomal cell death...|$|R
40|$|Although {{oligomeric}} β-amyloid (Aβ) {{has been}} suggested to {{have an important role}} in Alzheimer disease (AD), the mechanism(s) of how Aβ induces <b>neuronal</b> cell <b>death</b> has not been fully identified. The balance of pro- and anti-apoptotic Bcl- 2 family proteins (e. g., Bcl- 2 and Bcl-w versus Bad, Bim and Bax) has been known to have a role in <b>neuronal</b> cell <b>death</b> and, importantly, expression levels of these proteins are reportedly altered in the vulnerable neurons in AD. However, the roles of apoptotic proteins in oligomeric Aβ-induced cell death remain unclear in vivo or in more physiologically relevant models. In addition, no study to date has examined whether Bax is required for the toxicity of oligomeric Aβ. Here, we found that treatment with oligomeric Aβ increased Bim levels but decreased Bcl- 2 levels, leading to the activation of Bax and <b>neuronal</b> cell <b>death</b> in hippocampal slice culture and in vivo. Furthermore, the inhibition of Bax activity either by Bax-inhibiting peptide or bax gene knockout significantly prevented oligomeric Aβ-induced <b>neuronal</b> cell <b>death.</b> These findings are first to demonstrate that Bax has an essential role in oligomeric Aβ-induced <b>neuronal</b> cell <b>death,</b> and that the targeting of Bax may be a therapeutic approach for AD...|$|R
40|$|Caspase-independent death {{mechanisms}} {{have been}} shown to execute apoptosis in many types of neuronal injury. P 53 has been identified as a key regulator of <b>neuronal</b> cell <b>death</b> after acute injury such as DNA damage, ischemia, and excitotoxicity. Here, we demonstrate that p 53 can induce <b>neuronal</b> cell <b>death</b> via a caspase-mediated process activated by apoptotic activating factor- 1 (Apaf 1) and via a delayed onset caspase-independent mechanism. In contrast to wild-type cells, Apaf 1 -deficient neurons exhibit delayed DNA fragmentation and only peripheral chromatin condensation. More importantly, we demonstrate that apoptosis-inducing factor (AIF) is an important factor involved in the regulation of this caspase-independent <b>neuronal</b> cell <b>death.</b> Immunofluorescence studies demonstrate that AI F is released from the mitochondria by a mechanism distinct from that of cytochrome-c in neurons undergoing p 53 -mediated cell death. The Bcl- 2 family regulates this release of AIF and subsequent caspase-independent cell death. In addition, we show that enforced expression of AIF can induce <b>neuronal</b> cell <b>death</b> in a Bax- and caspase-independent manner. Microinjection of neutralizing antibodies against AIF significantly decreased injury-induced <b>neuronal</b> cell <b>death</b> in Apaf 1 -deficient neurons, indicating its importance in caspase-independent apoptosis. Taken together, our results suggest that AIF may be an important therapeutic target for the treatment of neuronal injury...|$|R
2500|$|Multiple {{studies have}} {{reported}} that environmental enrichment for adult mice helps relieve <b>neuronal</b> <b>death,</b> which is particularly beneficial to those with Parkinson's disease. A more recent study shows that environmental enrichment particularly affects the nigrostriatal pathway, which is important for managing dopamine and acetylcholine levels, critical for motor deficits. [...] Moreover, {{it was found that}} environmental enrichment has beneficial effects for the social implications of Parkinson's disease.|$|E
2500|$|Like other NMDA antagonists, [...] was {{suggested}} to produce neurotoxicity {{in the form}} of Olney's lesions in rodents upon prolonged (several hour) exposure. New research has arisen suggesting that Olney's lesions do not occur in humans, however, and similar drugs such as ketamine are now believed not to be acutely neurotoxic. It has been argued that, because [...] has a very short duration under normal circumstances, it is less likely to be neurotoxic than other NMDA antagonists. Indeed, in rodents, short-term exposure results in only mild injury that is rapidly reversible, and permanent <b>neuronal</b> <b>death</b> only occurs after constant and sustained exposure. Nitrous oxide also may cause neurotoxicity after extended exposure because of hypoxia. This is especially true of non-medical formulations such as whipped-cream chargers (also known as [...] "whippets" [...] or [...] "nangs"), which never contain oxygen, since oxygen makes cream rancid.|$|E
2500|$|Brain {{plasticity}} {{refers to}} the brain's ability to change structure and function. This ties into the common phrase, [...] "if you don't use it, you lose it," [...] which {{is another way of}} saying, if you don't use it, your brain will devote less somatotopic space for it. One proposed mechanism for the observed age-related plasticity deficits in animals is the result of age-induced alterations in calcium regulation. [...] The changes in our abilities to handle calcium will ultimately influence neuronal firing and the ability to propagate action potentials, which in turn would affect the ability of the brain to alter its structure or function (i.e. its plastic nature). Due to the complexity of the brain, with all of its structures and functions, it is logical to assume that some areas would be more vulnerable to aging than others. Two circuits worth mentioning here are the hippocampal and neocortical circuits. [...] It has been suggested that age-related cognitive decline is due in part not to <b>neuronal</b> <b>death</b> but to synaptic alterations. Evidence in support of this idea from animal work has also suggested that this cognitive deficit is due to functional and biochemical factors such as changes in enzymatic activity, chemical messengers, or gene expression in cortical circuits.|$|E
50|$|Interfering with GRIK4/KA1 {{function}} {{with a specific}} anti-KA1 antibody protects against kainate-induced <b>neuronal</b> cell <b>death.</b>|$|R
40|$|Experimental {{cerebral}} malaria (ECM) resulting from Plasmodium berghei ANKA (PbA) infection in mice results in <b>neuronal</b> cell <b>death.</b> However, the precise mechanisms leading to <b>neuronal</b> cell <b>death</b> in ECM {{have not been}} fully elucidated. In the present study, we report the presence of endoplasmic reticulum (ER) stress markers and activation of the unfolded protein response (UPR) in the brain during the pathogenesis of ECM. Specific findings included activation of PKR-like ERkinase, inositol-requiring enzyme 1 and cleavage of activating transcription factor (ATF) 6 indicating the activation of all three major arms of the UPR. Further, we found changes in the protein levels of phosphorylated eukaryotic initiation factor α (p-eIF 2 α), ATF 4, growth arrest and DNA damage-inducible protein 34, B cell lymphoma protein 2 (BCL- 2), BCL- 2 -associated X protein, caspase- 7, cleavage of caspase- 3, and caspase- 12. Our results demonstrate that ER stress-induced <b>neuronal</b> cell <b>death</b> in PbA-infected mice {{is associated with the}} expression of the pro-apoptotic molecule CHOP and downregulation of anti-apoptotic ER quality control molecules binding immunoglobulin protein, calreticulin and calnexin. Further CHOP was found to be localized in neurons and plays an essential role in <b>neuronal</b> cell <b>death</b> as revealed by our Fluoro-Jade B double staining. These results implicate an imbalance between ER stress-mediated pro-apoptotic and anti-apoptotic/survival signalling as a critical determinant of <b>neuronal</b> cell <b>death</b> in ECM...|$|R
30|$|This study thus {{suggests}} that Peltophorum pterocarpum leaf extract has neuroprotective activity against oxidative-stress induced <b>neuronal</b> cell <b>death.</b>|$|R
2500|$|Systems biology {{approaches}} to Alzheimer’s disease that consider the biochemical pathways {{that are important}} in CNS disease evolution have been developed by research that was funded outside NASA. Figure 6-8 shows a schematic of the biochemical pathways {{that are important in}} the development of Alzheimer’s disease. The description of the interaction of space radiation within these pathways would be one approach to developing predictive models of space radiation risks. For example, if the pathways that were studied in animal models could be correlated with studies in humans who are suffering from Alzheimer’s disease, an approach to describe risk that uses biochemical degrees-of-freedom could be pursued. Edelstein-Keshet and Spiros [...] have developed an in silico model of senile plaques that are related to Alzheimer’s disease. In this model, the biochemical interactions among TNF, IL-1B, and IL-6 are described within several important cell populations, including astrocytes, microglia, and neurons. Further, in this model soluble amyloid causes microglial chemotaxis and activates IL-1B secretion. Figure 6-9 shows the results of the Edelstein-Keshet and Spiros model simulating plaque formation and <b>neuronal</b> <b>death.</b> Establishing links between space radiation-induced changes to the changes that are described in this approach can be pursued to develop an in silico model of Alzheimer’s disease that results from space radiation.|$|E
2500|$|In {{addition}} to the neurotoxic effects of ethanol in mature organisms, chronic ingestion is capable of inducing severe developmental defects. Evidence was first shown in 1973 of a connection between chronic ethanol intake by mothers and defects in their offspring. This work was responsible for creating the classification of fetal alcohol syndrome; a disease characterized by common morphogenesis aberrations such as defects in craniofacial formation, limb development, and cardiovascular formation. The magnitude of ethanol neurotoxicity in fetuses leading to fetal alcohol syndrome {{has been shown to}} be dependent on antioxidant levels in the brain such as vitamin E. As the fetal brain is relatively fragile and susceptible to induced stresses, severe deleterious effects of alcohol exposure can be seen in important areas such as the hippocampus and cerebellum. The severity of these effects is directly dependent upon the amount and frequency of ethanol consumption by the mother, and the stage in development of the fetus. It is known that ethanol exposure results in reduced antioxidant levels, mitochondrial dysfunction (Chu 2007), [...] and subsequent <b>neuronal</b> <b>death,</b> seemingly as a result of increased generation of reactive oxidative species (ROS). This is a plausible mechanism, as there is a reduced presence in the fetal brain of antioxidant enzymes such as catalase and peroxidase. In support of this mechanism, administration of high levels of dietary vitamin E results in reduced or eliminated ethanol-induced neurotoxic effects in fetuses.|$|E
50|$|SUCLG2 {{may also}} play a role in {{clearing}} cerebrospinal fluid amyloid-beta 1-42 (Aβ1-42) in Alzheimer's disease (AD) and, thus, reducing <b>neuronal</b> <b>death.</b>|$|E
50|$|Secondly, Kalkitoxin blocks {{voltage-gated}} sodium channels, thereby inhibiting Ca2+ {{release that}} normally {{occurs when the}} voltage-gated sodium channel is activated, in a concentration dependent matter. Calcium release {{has been shown to}} induce lactate dehydrogenase (LDH) production. The amount of LDH is a measure for <b>neuronal</b> cell <b>death.</b> In the presence of kalkitoxin there is also a concentration-dependent inhibition of <b>neuronal</b> cell <b>death</b> and LDH production (9). The mechanism behind this inhibition is still unknown.|$|R
40|$|Glutamate {{excitotoxicity}} {{mediated by}} N-methyl-d-aspartate (NMDA) receptors {{is an important}} cause of retinal ganglion cell death in glaucoma. To elucidate whether apelin protects against retinal <b>neuronal</b> cell <b>death,</b> we examined protective effects of exogenous and endogenous apelin on <b>neuronal</b> cell <b>death</b> induced by intravitreal injection of NMDA in the retinas of mice. An intravitreal injection of NMDA induced <b>neuronal</b> cell <b>death</b> in both the retinal ganglion cell layer and inner nuclear layer, and reduced the amplitudes of scotopic threshold response (STR) in electroretinography studies. Both cell death and STR amplitudes decrease induced by NMDA were prevented by a co-injection of [Pyr 1]-apelin- 13, and were facilitated by apelin deficiency. The neuroprotective effects of [Pyr 1]-apelin- 13 were blocked by an apelin receptor APJ antagonist, and by inhibitors of Akt and extracellular signal-regulated kinase 1 / 2 signaling pathways. Additionally, an intravitreal injection of tumor necrosis factor-α (TNF-α) neutralizing antibody prevented NMDA-induced retinal <b>neuronal</b> cell <b>death,</b> and exogenous and endogenous apelin suppressed NMDA-induced upregulation of TNF-α in the retina. These results suggest that apelin protects neuronal cells against NMDA-induced death via an APJ receptor in the retina, and that apelin may have beneficial effects {{in the treatment of}} glaucoma...|$|R
40|$|In a {{substantial}} number of cases, Human Immunode�ciency Virus type 1 (HIV- 1) infection causes neuronal cell loss and leads to the development of AIDS associated dementia. Several studies have suggested that both host and viral factors contribute to neuronal loss. Here we studied the effect of HIV- 1 Tat in primary rat neuronal cells as a model to understand mechanism of <b>neuronal</b> cell <b>death.</b> At nano molar concentration, recombinant Tat induced cell death in primary rat mixed cortical neurons. Tat could also induce uptake of calcium in primary rat cultures. When cells were incubated with NMDA receptor antagonists, MK- 801 and D-CPP, cell death and 45 Ca uptake were inhibited. Under similar conditions non-NMDA antagonists, NBQX, DNQX and CNQX, and sodium channel antagonist, TTX, did not inhibit Tat induced <b>neuronal</b> cell <b>death.</b> In a similar way HIV associated products from in vitro HIV- 1 infected cells induced <b>neuronal</b> cell <b>death</b> which was inhibited by NMDA receptor antagonist. Results presented in this paper suggest that activation of NMDA receptors by HIV- 1 Tat is responsible for <b>neuronal</b> cell <b>death</b> in primary rat cortical neurons. Journa l of Ne uro Virology (2001) 7, 1...|$|R
50|$|Overall, {{pulmonary}} arterial {{tension and}} acute coronary syndromes are {{few of the}} many diseases that lead to hypoxia of neuronal tissue, which in turns deteriorates the haemodynamic response and leads to <b>neuronal</b> <b>death.</b> Prolonged hypoxia induces <b>neuronal</b> <b>death</b> via apoptosis. With a dysfunctional haemodynamic response, active neuronal tissue due to membrane depolarization lacks the necessary energy to propagate signals, {{as a result of}} blood flow hindrance. This affects many functions in the body, and may lead to severe symptoms.|$|E
50|$|The {{pathophysiology}} of Parkinson's {{disease is}} death of dopaminergic neurons {{as a result}} of changes in biological activity in the brain with respect to Parkinson's disease (PD). There are several proposed mechanisms for <b>neuronal</b> <b>death</b> in PD; however, not all of them are well understood. Five proposed major mechanisms for <b>neuronal</b> <b>death</b> in Parkinson's Disease include protein aggregation in Lewy bodies, disruption of autophagy, changes in cell metabolism or mitochondrial function, neuroinflammation, and blood-brain barrier (BBB) breakdown resulting in vascular leakiness.|$|E
50|$|These {{studies suggest}} that reduced PtdIns(3,5)P2 levels, by a yet-to-be {{identified}} mechanism, mediate <b>neuronal</b> <b>death.</b> In contrast, MTMR2 phosphatase knockout, which also causes peripheral neuropathy, is accompanied by elevation in PtdIns(3,5)P2.|$|E
40|$|AbstractIn Alzheimer’s disease, {{cytochrome}} c-dependent apoptosis is {{a crucial}} pathway in <b>neuronal</b> cell <b>death.</b> Although beta-amyloid (Aβ) oligomers {{are known to be}} the neurotoxins responsible for <b>neuronal</b> cell <b>death,</b> the underlying mechanisms remain largely elusive. Here, we report that the oligomeric form of synthetic Aβ of 42 amino acids elicits death of HT- 22 cells. But, when expression of a bcl- 2 family protein BAK is suppressed by siRNA, Aβ oligomer-induced cell death was reduced. Furthermore, significant reduction of cytochrome c release was observed with mitochondria isolated from BAK siRNA-treated HT- 22 cells. Our in vitro experiments demonstrate that Aβ oligomers bind to BAK on the membrane and induce apoptotic BAK pores and cytochrome c release. Thus, the results suggest that Aβ oligomers function as apoptotic ligands and hijack the intrinsic apoptotic pathway to cause unintended <b>neuronal</b> cell <b>death...</b>|$|R
40|$|The {{major goal}} {{of this study was}} to compare {{mechanisms}} of the neuroprotective potential of 17 �-estradiol in two models for oxidative stress-independent apoptotic <b>neuronal</b> cell <b>death</b> with that in necrotic <b>neuronal</b> cell <b>death</b> in primary <b>neuronal</b> cultures derived from rat hippocampus, septum, or cortex. Neuronal apoptosis was induced either by staurosporine or ethylcholine aziridinium (AF 64 A), as models for necrotic cell death glutamate exposure or oxygen–glucose deprivation (OGD) were applied. Long-term (20 hr) pretreatment (0. 1 �M 17 �-estradiol) was neuroprotective in apoptotic <b>neuronal</b> cell <b>death</b> induced by AF 64 A (40 �M) only in hippocampal and septal neuronal cultures and not in cortical cultures. The neuroprotective effect was blocked by the estrogen antagonists ICI 182, 780 and tamoxifen and the phosphatidylinositol 3 -kinase (PI 3 -K) inhibitor LY 294002. In glutamate and OGD-induced neuronal damage...|$|R
40|$|The {{dysfunction}} of proteasomes and mitochondria {{has been}} implicated in the pathogenesis of Parkinson disease. However, the mechanism by which this dysfunction causes <b>neuronal</b> cell <b>death</b> is unknown. We studied the role of cyclin-dependent kinase 5 (Cdk 5) -p 35 in the <b>neuronal</b> cell <b>death</b> induced by 1 -methyl- 4 -phenylpyrinidinium ion (MPP+), which {{has been used as}} an in vitro model of Parkinson disease. When cultured neurons were treated with 100 μm MPP+, p 35 was degraded by proteasomes at 3 h, much earlier than the neurons underwent cell death at 12 – 24 h. The degradation of p 35 was accompanied by the down-regulation of Cdk 5 activity. We looked for the primary target of MPP+ that triggered the proteasome-mediated degradation of p 35. MPP+ treatment for 3 h induced the fragmentation of the mitochondria, reduced complex I activity of the respiratory chain without affecting ATP levels, and impaired the mitochondrial import system. The dysfunction of the mitochondrial import system is suggested to up-regulate proteasome activity, leading to the ubiquitin-independent degradation of p 35. The overexpression of p 35 attenuated MPP+-induced <b>neuronal</b> cell <b>death.</b> In contrast, depletion of p 35 with short hairpin RNA not only induced cell death but also sensitized to MPP+ treatment. These results indicate that a brief MPP+ treatment triggers the delayed <b>neuronal</b> cell <b>death</b> by the down-regulation of Cdk 5 activity via mitochondrial dysfunction-induced up-regulation of proteasome activity. We propose a role for Cdk 5 -p 35 as a survival factor in countering MPP+-induced <b>neuronal</b> cell <b>death...</b>|$|R
